Stanol esters as a component of maximal dietary therapy in the National Cholesterol Education Program Adult Treatment Panel III Report

被引:48
|
作者
Grundy, SM
机构
[1] Univ Texas, SW Med Ctr, Ctr Human Nutr, Dallas, TX 75390 USA
[2] Univ Texas, SW Med Ctr, Dept Clin Nutr, Dallas, TX USA
[3] Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX USA
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2005年 / 96卷 / 01期
关键词
D O I
10.1016/j.amjcard.2005.03.020
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Use of plant stanols/sterols in forms that are sufficiently bioavailable for therapeutic effect should be a key element of maximal dietary therapy. This principle was recognized by National Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATP III) and has been amply confirmed by experimental studies in humans. Since the introduction of statins, dietary therapy for control of elevated low-density lipoprotein (LDL) cholesterol levels has received less attention. The time has come, however, to reassert the importance of maximal dietary therapy as a cost-effective means for treatment of elevated LDL concentrations and for lifetime prevention of coronary heart disease. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:47D / 50D
页数:4
相关论文
共 50 条
  • [1] New therapeutic options in the National Cholesterol Education Program Adult Treatment Panel III
    Talbert, RL
    AMERICAN JOURNAL OF MANAGED CARE, 2002, 8 (12): : S301 - S307
  • [2] Role of the National Cholesterol Education Program Adult Treatment Panel III guidelines in managing dyslipidemia
    Talbert, RL
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2003, 60 (13) : S3 - S8
  • [3] Recent National Cholesterol Education Program Adult Treatment Panel III update: Adjustments and options
    Stone, NJ
    Bilek, S
    Rosenbaum, S
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (4A): : 53E - 59E
  • [4] Update on the National Cholesterol Education Program Adult Treatment Panel III guidelines: Getting to goal
    McKenney, JM
    PHARMACOTHERAPY, 2003, 23 (09): : 26S - 33S
  • [5] National Cholesterol Education Program Adult Treatment Panel III guidelines and obesity: Implications for Canada
    Ardern, CI
    Katzmarzyk, PT
    CANADIAN JOURNAL OF CARDIOLOGY, 2003, 19 (10) : 1171 - 1177
  • [6] The impact of the National Cholesterol Education Program Adult Treatment Panel III guidelines on drug development
    Isaacsohn, J
    Black, D
    Troendle, A
    Orloff, D
    AMERICAN JOURNAL OF CARDIOLOGY, 2002, 89 (5A): : 45C - 49C
  • [7] Niacin and the National Cholesterol Education Program Adult Treatment Panel III guidelines: Case studies
    Talbert, RL
    Pieper, JA
    Ito, MK
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2003, 60 (13) : S22 - S24
  • [8] Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, R
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Cleeman, JI
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    Keller, SA
    Jehle, AJ
    CIRCULATION, 2002, 106 (25) : 3143 - 3421
  • [9] Impact of the third cholesterol report from the Adult Treatment Panel of the National Cholesterol Education Program on the clinical laboratory
    Warnick, GR
    Myers, GL
    Cooper, GR
    Rifai, N
    CLINICAL CHEMISTRY, 2002, 48 (01) : 11 - 17
  • [10] Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines
    Cheng, Alice Y. Y.
    Leiter, Lawrence A.
    CURRENT OPINION IN CARDIOLOGY, 2006, 21 (04) : 400 - 404